ChemPlusChem

Cover image for Vol. 82 Issue 4

Editor: Marisa Spiniello. Editorial Board Chairs: Matthias Driess, Michal Hocek, Tetsuro Majima

Online ISSN: 2192-6506

Associated Title(s): Angewandte Chemie International Edition, Chemistry - A European Journal

Notice to Authors

General Information

About the Journal

ChemPlusChem—A Genuinely Multidisciplinary Journal Centering on Chemistry is a peer-reviewed scientific journal tailored to multidisciplinary chemistry researchers from across the world. Fully comprehensive in its scope, ChemPlusChem publishes original papers describing new results that cover at least two different aspects (subfields) of chemistry or one of chemistry and one of another scientific discipline (one chemistry topic plus another one, hence the title ChemPlusChem).

ChemPlusChem is co-owned by a group of European chemical societies (ChemPubSoc Europe); they are: the chemical societies of Austria (GÖCh), Belgium (SRC and KVCV), the Czech Republic (ČSCH), France (SFC), Germany (GDCh), Greece (AGS), Hungary (MKE), Italy (SCI), the Netherlands (KNCV), Poland (PTCh), Portugal (SPQ), Spain (RSEQ), and Sweden (SCS) with support from the chemical societies of Slovakia (SCS) and Switzerland (SCG). The journal is published by Wiley-VCH. ChemPlusChem is a member of the growing family of ChemPubSoc Europe journals that include Chemistry—A European Journal, European Journal of Inorganic Chemistry, European Journal of Organic Chemistry, ChemBioChem, ChemCatChem, ChemElectroChem, ChemMedChem, ChemPhotoChem, ChemPhysChem, ChemSusChem, ChemistrySelect and ChemistryOpen. The Journal is fully electronic and available online. ChemPlusChem publishes 12 online issues per year and succeeds the Collection of Czechoslovak Chemical Communications, which ceased publication at the end of 2011.

ChemPlusChem publishes an attractive mix of Full Papers, Communications, Reviews, and Minireviews. Except for original research papers (Communications and Full Papers) all other article types are generally invited. Unsolicited manuscripts are welcome as long as they fit the scope of the journal. It would, however, be helpful if the Editor is informed of the topic and outline of a proposed Review or Minireview prior to submission.

We encourage the use of color to enhance the readability of results. Color is free to all authors.

Editorial Policies

ChemPlusChem does not publish manuscripts that have already appeared in print or electronically. The author must inform the Editor of manuscripts submitted, soon to be submitted, or in press at other journals that have a bearing on the manuscript being submitted to ChemPlusChem. If the manuscript is, in fact, a revised/extended version of a manuscript previously rejected by ChemPlusChem, the author must inform the editor about the previous submission in the cover letter and explain in detail the essential changes that have been made. The Ethical Guidelines for Publication in Journals and Reviews issued by European Association of Chemical and Molecular Sciences are followed and applied by the Editors of ChemPlusChem. Japanese and Chinese translations of Wiley-Blackwell′s Publication Ethics: Best Practice Guidelines on Publication Ethics: A Publisher′s Perspective are available on the Wiley–Blackwell author services homepage and also through the ChemPlusChem homepage (www.chempluschem.org).

In particular, authors should reveal all sources of funding for the work presented in the manuscript and declare any conflict of interest in their cover letter to the editor, for example support of the research by companies who stand to profit from publication of the results. In cases of suspected plagiarism, submitted manuscripts will be checked with relevant software. Honorary authorship is forbidden, i.e., all co-authors of a manuscript must have contributed significantly to the work being described and/or to the writing of research proposals or the manuscript. In cases of more than three authors, the contribution of each author should be explained in the cover letter. Every author must be informed about the submission and must have agreed to it.

The essential findings presented in a Communication or Full Paper or significant parts of them may not already have appeared in print or in electronic online systems (for example, in online resources, in reviews, proceedings, or preprints). Contributions that do not fulfill the criteria mentioned will be returned to the authors without further external review.

Authors submitting a manuscript to ChemPlusChem for the first time are asked to characterize their main research interests with a maximum of five keywords from the Keyword List for Authors and Reviewers (see our basic keyword list for details).

All manuscripts that are suitable for consideration will be peer reviewed and, if accepted for publication, edited with a view to clarity, brevity, and consistency. The conditions for publication are available on the journal′s homepage. Authors are welcome to suggest reviewers.

If a manuscript was previously submitted to Angewandte Chemie, Chemistry–A European Journal, ChemCatChem, ChemSusChem or any other of ChemPlusChem′s sister journals, then please state the manuscript number of the previous submission in the cover letter. This will help the peer-review process.

In the event of acceptance, papers can be published online as Accepted Articles prior to editing and proofing. Please indicate if you wish to have your paper published online as an Accepted Article by ticking or unticking the relevant box in the submission system when submitting your Copyright Transfer Agreement. If you wish to have your article published as soon as possible online as an Accepted Article, the final version of the manuscript must be submitted in the appropriate template. Please also ensure that the order of authors and title in the submission system match those in the final version of the manuscript before submitting the final version after acceptance. Corrections will be incorporated only through the editing and proofing process.

The author who submitted the article, which should typically be the correspondence (*) author, will receive page proofs as a compressed PDF file and a Word file. Corrections may be included either as comments in the PDF or as tracked changes in the Word document. Corrections should be returned to the Editorial Office within two days. The main correspondence author will also receive a reprint PDF file, restricted to 25 printouts, free of charge upon publication of the article in an issue of the journal. Additional reprints may be purchased, and an order form is provided along with the page proofs.

Corrections after "Early View" and before issue publication will be accepted only if formal aspects or "misprints" are concerned. For all other corrections, such as those regarding scientifically incorrect or incomplete information, a Corrigendum has to be submitted. Please contact the Editorial Office in such cases.

If authors are mandated or want to make their publications freely available from the moment they are published (open access), ChemPlusChem offers such a service. In the OnlineOpen section on our homepage you can find all of the information about this subject. ChemPlusChem also complies with the request or mandate from research funding agencies, for example, the US National Institutes of Health (NIH), to make manuscripts freely available online in the unedited and not proof-read form after acceptance.

In general, we recommend that authors link to their ChemPlusChem publication on their homepage through the "Digital Object Identifier" (DOI). It is only in this way that the Crossref function and full-text downloads can be correctly tallied.

A video summary can be a quick way to make the message of your research accessible to a much larger audience. Wiley-VCH and its partner Research Square offer a service of professionally produced video summaries, available to authors of articles accepted in this journal. You can learn more about it, and purchase one for your article, at https://www.researchsquare.com/wiley. If you have any questions, please direct them to videoabstracts@wiley.com.

Queries regarding manuscripts should be sent to chempluschem@wiley-vch.de. The official Chemical Abstracts Service Source Index (CASSI) abbreviation for ChemPlusChem is the same as the title, "ChemPlusChem" (all one word, no spaces or punctuation).

Manuscript Submission

Contributions should be in English and we request that you submit your manuscript by using our online submission system, Editorial Manager, accessible either through our homepage (www.chempluschem.org) via the "Submit an Article" link or directly via www.editorialmanager.com/cplu. For the initial submission of a manuscript, please prepare a single file (allowed format: MicrosoftWord .docx) containing all Schemes, Figures, Tables, etc. These elements should be integrated into the text (i.e., inserted where first mentioned), to facilitate evaluation by the Editor and Reviewers. Supporting Information, crystallographic CIF files, and any other additional materials should also be provided during the submission process. A cover letter should be included, and we ask that it include a short text justifying why your article should appear in ChemPlusChem.

When you have all your files ready for submission, go to www.editorialmanager.com/cplu and login as an "Author". Click on "Submit a Manuscript" and follow the step-by-step instructions. Please note that you will be required to view the generated PDF and confirm that it is suitable before the submission process can be completed.

If, for any reason, you are unable to use our online submission site, then you can also send the manuscript to us as a single PDF file along with any Supporting Information and the cover letter via email to chempluschem@wiley-vch.de. Please note, however, that online submission is preferred, as this will considerably speed up the manuscript-handling process.

Types of Contributions

Reviews

Reviews deal with topics of current interest to the general chemistry readership of ChemPlusChem. Rather than an assemblage of detailed information with a complete literature survey, a critical but balanced and scholarly survey of recent developments is desired. Unsolved problems and possible developments should also be discussed.

Reviews should consist of a maximum of approximately 65000 characters (excl. spaces) of main text, footnotes, literature citations, tables, and legends. Excessive jargon and too much technical detail should be avoided. References should be selective. Reviews should be divided into sections (that are not numbered). Reviews starts with an Abstract (maximum 1000 characters excl. spaces, no references). This text should not be a mere summary, but rather should—together with a frontispiece picture—arouse the readers′ interest.

The article itself is then structured with the following sections: 1) Introduction; 2) Body (with headings and subheadings); 3) Summary and Outlook. The Introduction should introduce the nonspecialist to the subject as clearly as possible. A Review should conclude with a Summary and Outlook section, in which the achievements and new challenges for the subject are presented succinctly. In addition, a biographical sketch (up to 500 characters excl. spaces) and a portrait-quality color photograph of each author, as well as a graphical suggestion for a full-page picture (frontispiece; 18 cm wide × 19.5 cm high) to face the first page of the review article, should be submitted. The publication of a color frontispiece is free of charge.

Reviews are mostly written upon invitation; however, independent submissions are welcome if they are written according to the guidelines above.

Three weeks are allowed for the revision of a Review. If more time is needed the Editor should be informed.

Minireviews

Minireviews introduces the reader to a particular area of an author′s research through a concise overview of a selected topic. Minireviews offer the flexibility to treat topics at a time, and in a suitable manner, when a Review would still be premature or inappropriate. The content should balance scope with depth, and references to important works from others that are significant to the topic, should be included.

Minireviews should consist of a maximum of approximately 25000 characters (excl. spaces) of main text, footnotes, literature citations, tables, and legends. Excessive jargon and too much technical detail should be avoided. References should be selective. Reviews should be divided into sections (that are not numbered). Minireviews starts with an Abstract (maximum 1000 characters excl. spaces, no references). This text should not be a mere summary, but rather should—together with a frontispiece picture—arouse the readers′ interest.

The article itself is then structured with the following sections: 1) Introduction; 2) Body (with headings and subheadings); 3) Summary and Outlook. The Introduction should introduce the nonspecialist to the subject as clearly as possible. A Minireview should conclude with a Summary and Outlook section, in which the achievements and new challenges for the subject are presented succinctly. In addition, a biographical sketch (up to 500 characters excl. spaces) and a portrait-quality color photograph of the corresponding author(s) only, as well as a graphical suggestion for a full-page picture (frontispiece; 18 cm wide × 19.5 cm high) to face the first page of the Minireview article, should be submitted. The publication of a color frontispiece is free of charge.

Minireviews are mostly written upon invitation; however, independent submissions are welcome if they are written according to the guidelines above.

Three weeks are allowed for the revision of a Minireview. If more time is needed the Editor should be informed.

Communications and Full Papers

Communications and Full Papers present multidisciplinary results of experimental and/or theoretical studies of general interest or great importance to the development of a specific area of research. A short text justifying why the manuscript should appear in ChemPlusChem should be included in the cover letter provided upon submission. The essential findings presented in a Communication or Full Paper or significant parts of them may not already have appeared in print or in electronic form (including, for example, in online resources, in reviews, proceedings, or preprints). Contributions that are too specialized for the general readership of ChemPlusChem will be returned to the authors without further external review. The quality of original research contributions is usually assessed by two or more independent reviewers; authors are welcome to suggest reviewers. On the basis of the recommendations of the referees, the Editor will make a decision on whether to accept a contribution.

Reviewers have the responsibility to return the manuscript without review to the editor if there is a conflict of interest. Specifically, reviewers should not review manuscripts authored or co-authored by a person with whom the reviewer has a close personal or professional relationship, if this relationship could be reasonably thought to bias the review.

Detailed information that could be of importance to the reviewers, but that is unlikely to be of interest to the reader can be submitted as an enclosure or clearly marked as Supporting Information.

Only articles that have already been published in a scientific journal should be cited. Articles available online that have not yet been assigned page numbers should be cited using the "digital object identifier" (DOI). The citation should be fair and informative but not excessive. Copies of cited publications not yet available publicly should be submitted along with the manuscript. Unpublished results and lectures should only be cited in exceptional circumstances.

Each Communication and Full Paper contains an Abstract. In this abstract, the motivation for the work, the methods applied, the results, and the conclusions drawn should be concise (maximum 1000 characters excl. spaces, no references) not too technical, and should stand alone. When you write the abstract, please keep the following aspects in mind: 1) The abstract should awaken the curiosity of as many readers as possible. 2) The abstract should reflect the content of the paper, and the text should contain several keywords to aid finding the paper online. 3) The abstract should contain neither allusions to graphical elements or tables in the paper or to references, as the abstract will be found independently, for example in databases. 4) Please define abbreviations and restrict their use to a minimum.

Communications should be no longer than approximately 15000 characters, including all references, footnotes, and tables. Chemical formulae, figures, and schemes may also be added. Longer Communications will be accepted only if their quality warrants special consideration, and a written justification of their length should be provided. Communications should not be divided into sections; however, experimental or computational details can be summarized separately under the heading Experimental Section or Computational Methods. Please note, only pertinent experimental information should be included in this section, and any additional experimental data should be detailed in the Supporting Information. Click here for details about Experimental Section requirements. The main text of a Communication should start by giving an introduction to enable readers unfamiliar with the subject to become acquainted with the importance of the results presented. In the final paragraph the results should be summarized succinctly, and one sentence should be devoted to their significance and, if appropriate, to remaining challenges.

Three weeks are allowed for the revision of a Communication. If more time is needed the Editor should be informed.

Full Papers, which generally contain an Experimental Section and/or Computational Methods (see our detailed Experimental Section requirements), have no length restrictions. However, the Editorial Office requests that space be used thoughtfully and economically. ChemPlusChem will not publish Full Papers that consist mainly of results reported in previous Communications with an added Experimental Section. Full Papers contain an Introduction that includes relevant references. The presentation of Results and Discussion may be combined or kept separate. These sections may be further divided by subheadings. The main text of a Full Paper should close with a Conclusion section, summarizing the key findings and future directions.

Three weeks are allowed for the revision of a Full Paper. If more time is needed the Editor should be informed.

Viewpoints

Opinion-based articles on topics of high current interest are published as Viewpoints in ChemPlusChem. These articles are contributions in which any author gives their own thoughts on important developments in a specific area of the chemical sciences and the implications for future research. Viewpoints may be controversial, and while the Author should put forward their own point of view, they should not ignore the counter arguments but rather refute them through discussion. The reference section should include only the key papers in the field under discussion, rather than being fully comprehensive. A Viewpoint should aim to provide both the nonspecialist reader and expert with a thought-provoking discussion. Viewpoints usually only have one Author who should be a leader in the field on which their Viewpoint is based. Viewpoints may be organized as the author wishes, but should include a short Abstract (maximum 800 characters excl. spaces) that succinctly describes the context and the point of view being presented. Viewpoints should be not more than 15000–17000 characters, including references, tables, and legends. The conservative use of schemes and figures is recommended. The final paragraph or section of a Viewpoint should summarize the motivation behind the Viewpoint and the core conclusions arising from the discussion put forward.

Correspondence

Critical comments on publications in ChemPlusChem are welcome if they contribute to scientific discussion. The author of the publication to which the Correspondence pertains will have the opportunity to reply. This reply will be sent to the author of the Correspondence. Authors interested in preparing such a contribution should contact the Editor to discuss this further (chempluschem@wiley-vch.de).

Corrigenda

Post-publication correction of errors recognized only after an article has been published is possible. How the correction is carried out depends on the severity of the error. Minor typographical errors and misspellings are left alone as long as reader comprehension of the content remains unaltered. Minor scientifically incorrect or incomplete information in EarlyView articles can be corrected before the article´s final publication in an issue, and in these cases, a short text is added toward the end of the paper alerting readers that minor changes have been made since the initial online publication.

Significant scientific errors noted either after a manuscript´s publication in EarlyView or in an issue, should be corrected in a Corrigendum—which is as short as possible. All corrigenda are subject to approval by the Editor, and minor corrections will not be published. Corrigenda are published directly after the Table of Contents in the next available issue of the journal. Authors should first contact the editorial office before they submit the Corrigendum. We request that authors submit the Corrigendum electronically like any other article through Editorial Manager, and that they cite the publication to be corrected along with its digital object identifier (DOI).

Submission of the Original Manuscript

The following remarks aim to assist you in preparing your manuscript for submission to ChemPlusChem. We strongly encourage you to adhere closely to these guidelines as it facilitates the evaluation of your article by the Editors and Reviewers. Manuscripts that are not suitable for consideration by the reviewers because of poor presentation and poor language will be returned to the authors for improvement prior to being sent out for peer evaluation.

When you prepare the manuscript for initial submission and evaluation, we encourage the use of color where necessary to facilitate the scientific understanding and aid in the overall presentation of the manuscript. Color is free to all authors.

Authors are requested to submit their manuscripts through our online submission service Editorial Manager (www.editorialmanager.com/cplu). Please prepare two files, one containing the main manuscript (single-spaced text) with all graphics and tables integrated into the text; the other containing the Supporting Information (though not crystallographic CIF files, which should be deposited at the appropriate databank, such as the Cambridge Crystallographic Data Centre or FIZ Karlsruhe). Follow the instructions on the online submission website to upload these files. If you experience any problems please make use of the contact form at this site.

MS Word templates for Reviews, Minireviews, Communications, and Full Papers are available on our homepage in the section "Author Guidelines". Please use these templates only for the original submission of your contribution. We strongly encourage you to adhere closely to our detailed guidelines for manuscript preparation, this would significantly facilitates the peer-review process. Please prepare the final revised version of accepted contributions as described in the checklist that is attached to the acceptance letter.

If you use LaTeX, please send standard LaTeX files only and a PDF file of the manuscript; please do not include your own style sheets or macros. Basically, keep your file as simple as possible. It will not be used directly to typeset your manuscript, but will be converted prior to editing and typesetting (latex2rtf). For further details please consult our "Instructions for LaTeX users" on the ChemPlusChem homepage (www.chempluschem.org).

Authors of accepted manuscripts should refer to the specific requirements for the submission of the final revised version.

We encourage all authors to provide an ORCID identifier for each coauthor. ORCID is a registry that provides researchers with a unique digital identifier. Some funding agencies recommend or even require the inclusion of ORCID IDs in all published articles, and authors should consult their funding agency guidelines for details. Registration is easy and free; for further information, see "http://orcid.org/".

Either British or American spelling should be used throughout the manuscript—choose one and please be consistent. Authors are asked to make their manuscripts suitable for a heterogeneous readership—please use a simple, clear style, and avoid jargon. In some cases, it might be helpful to have manuscripts checked by a third party, such as Wiley English Language Editing Services, for correct language usage before submission.

Authors can follow the progress of their manuscript on their personal homepage (www.editorialmanager.com/cplu), which is created automatically upon initial registration. This homepage can be used to store all versions of a submitted paper and to upload the necessary production data after acceptance (see below); completed referee reports are also archived here.

Submission of the Final Revised Version (for Accepted Manuscripts)

The guidelines below are applicable only to authors of accepted manuscript who are preparing the final revised version. Authors preparing to submit an article to ChemPlusChem as a new submission should consult the section entitled "Manuscript Components".

If you submitted your original manuscript through Editorial Manager, you should upload your final version after acceptance through your homepage or by e-mail. Please note however, that the preferred method of submission of the final versions of manuscript is through your personal homepage. Please consult the checklist provided as an attachment to the acceptance letter to ensure that your manuscript complies with the journal requirements. If appropriate, a response letter should be provided outlining the changes made to the manuscript in response to the comments of the reviewers, or if you disagree with their suggestion(s), outlining your arguments against their remarks.

This final version should be provided either as a Word document (.docx) or in rich text format (.rtf) as one manuscript file containing all schemes, figures, tables, captions, and keywords and a separate file for the Supporting Information, if applicable. Please ensure that all panels and labels in each individual figure have been combined into a single image file before the figure is inserted into the document. You should then upload the manuscript by clicking on "Submit task" in production material upload within Editorial Manager. Further details will be provided upon acceptance of the manuscript. Not all graphics programs are suitable for use by our production team; details are provided in the checklist that is attached to the acceptance letter. If possible, the standard Symbol font should be used to create Greek letters, rather than special characters or graphics embedded in the text. All structural formulae should be provided as ChemDraw (.cdx) files.

Tables are edited in the text and therefore should not be sent as graphical elements but rather should be generated in Word and provided at the end of the manuscript text file. The tables should be set up with tabulators, not with the space bar or line breaks. Please avoid end-of-line word divisions; if necessary, these are included automatically by our typesetter and can be reviewed prior to publication in the page proofs. Please use only one font type, except for Greek letters, which should be typed in the Symbol font. The symbols for 1 (one) and l ("ell"), 0 (zero) and O ("oh") should be distinct.

Manuscript Components

Titles and Abstracts

To ensure discoverability of an article when published, authors should take care when drafting their Abstract and deciding on the wording of their Title.

The title should be as succinct as possible and without a reference. Words such as ′new′, ′novel′, ′first′, ′de novo′, and ′unprecedented′ in the title should be avoided. The title should be restricted to no more than 180 characters and be as informative as possible without being overly complicated. Key words and phrases should be used in the title and repeated in the abstract as appropriate.

For Full Papers and Communications, the Abstract should describe the motivation for the work, the methods applied, the key results, and the conclusions drawn. The Abstract for other contribution types should summarize the topic under discussion, the main findings and arguments, and place the article into context. Abstracts for Full Papers, Communications, Reviews and Minireviews should be a maximum 1000 characters (excl. spaces, no references) in length. In all cases, when you write the Abstract, please keep the following aspects in mind:

a) The abstract should awaken the curiosity of as many readers as possible.

b) The abstract should reflect the content of the paper, and the text should contain several keywords to aid finding the paper online.

c) The abstract must stand alone and should contain neither allusions to graphical elements or tables in the paper nor to references, etc., as the abstract will be found and read independently. Furthermore, bold-face compound numbers, while permitted, must be defined to allow the reader to mentally visualize the compound structure being discussed.

d) Please restrict the use of abbreviations to a minimum.

Graphical Abstract Entry

For all types of contributions, a graphical Table of Contents entry is included in both EarlyView and in the final Issue. A short text for the Table of Contents should be included upon submission. This text should be about six lines (approximately 350 characters excl. spaces) in length and formulated to arouse curiosity. Repetition or paraphrasing of the title and presentation of experimental details should be avoided. In addition, a simple color graphic to accompany the text should also be provided; the use of color in the Table of Contents is free of charge and strongly encouraged. Pictures should be kept small (5.5×5.0 cm or 11.0×2.5 cm) with minimum detail. Please restrict the use of text in the graphic and avoid large complicated schemes.

Cover Pictures

Suggestions for the cover pictures (18 cm wide × 17 cm high) with an explanatory text (maximum 500 characters excl. spaces) beginning with "The cover picture shows..." are welcome. For previous examples please see our (cover gallery. The cover pictures are chosen by the Editor shortly before an issue is to be published. As this offer provides the research of the authors with an increased visibility, we do ask for a fee to be paid by the author. Details are provided upon selection of the cover pictures.

Authors whose work appears on the front cover are asked to provide a Cover Profile. This feature is exclusive to the manuscript highlighted by the cover picture and gives authors the opportunity to showcase their group (and collaborators) as well as their research related to the paper. This separate one-page article includes photographs of the authors (or the group) as well as their response questions related to the research within the paper being highlighted on the cover. Again, details are provided upon selection of the front cover picture.

Supporting Information

Authors may provide Supporting Information when submitting a manuscript; upon acceptance the Supporting Information will be made available online via Wiley Online Library. In this event, the author should keep a copy to make available to readers who do not have internet access. All material that is intended to be published as Supporting Information should be presented succinctly (in English). This material is peer-reviewed and must therefore be included with the original submission. The author bears full responsibility for the content of the Supporting Information. After acceptance, succinct text and the necessary graphics should be submitted as a single separate PDF file along with the final revised version of the manuscript. Please do NOT include a Title/Authors page, as a cover page will be generated automatically during production.

In addition, the standard text: "Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/cplu.201xxxxx." should be added as a footnote after the addresses. Supporting Information should not include crystallographic data that are available from CCDC or FIZ.

Colors, animated multimedia applications, films, and so on are welcome and are published online at no cost to the author or reader. Please refer to such applications in the article itself where appropriate. These data should be uploaded to Editorial Manager or saved on a web server. If the files are saved on a web server, please send us the URL so we can download the files and make them available to referees and, if accepted, to readers. Please use suitable compression technology to avoid exceedingly large movie files (>10 MB) for the benefit of referees′ and readers′ bandwidth and storage capacity. Also, please make sure that your movies are saved in a common format (such as MPEG, AVI, QuickTime, GIF) that can be played on at least two different computer platforms (out of Windows/MacOS/Linux).

Contact Information

Regular mail: ChemPlusChem, Postfach 101161, 69451 Weinheim, Germany

Courier services: ChemPlusChem, Boschstrasse 12, 69469 Weinheim, Germany

Telephone: (+49)6201-606-305

Fax: (+49)6201-606-331 or -328

E-mail: chempluschem@wiley-vch.de

Homepage: http://www.chempluschem.org

Basic Keyword List

An interjournal browsing facility (automatic links to lists of thematically related contributions with a click of the mouse) has been developed for the readers of the Wiley-VCH journals Advanced Functional Materials, Advanced Materials, Advanced Synthesis & Catalysis, Angewandte Chemie International Edition, Asian Journal of Organic Chemistry, ChemBioChem, ChemCatChem, Chemistry—A European Journal, Chemistry—An Asian Journal, ChemCatChem, ChemElectroChem, ChemMedChem, ChemNanoMat, ChemPhotoChem, ChemPhysChem, ChemPlusChem, ChemSusChem, European Journal of Inorganic Chemistry, European Journal of Organic Chemistry, and Small, among others: www.wiley-vch.de/util/hottopics/. Manuscripts containing a hot topic as a keyword are automatically added to the relevant collection.

We have compiled a common keyword catalogue that is available online at www.wiley-vch.de/vch/journals/keyword.php. This catalogue is subdivided to facilitate the search for keywords but can also be searched as a complete list. Some of the keywords are used in more than one area. As with all such records, a few guidelines facilitate its use, and these are briefly explained below:

1.

At least two of the maximum of five keywords assigned to an article must come from this list.

2.

Compounds with inorganic components that are central to the article are listed under the element, for instance, iron complexes under "iron" and, if appropriate, the ligand type. Some group names such as "alkali metals" exist alongside the names of important members of the group, for example, "lithium". In such cases the group name is used for these members only when comparative studies are described. The members that do not appear separately are also categorized under the group name.

3.

Spectroscopic methods are assigned as keywords only if the article is about the method itself or if the spectroscopic technique has made an important contribution to the problem under investigation.

4.

"Structure elucidation" is intended only if the crux of the paper is a structural elucidation or if a combination of several spectroscopic techniques were needed for conclusive solution of the structure.

5.

An attempt should be made to avoid synonyms and to select more general concepts rather than specialized terms. Named reactions will be incorporated only in exceptional cases. Generally the reaction type is selected instead. For example, Diels–Alder reactions will be found under "cycloadditions" and Claisen rearrangements under "rearrangements". Heteroanalogues of compounds are mainly classified under the C variants, for example, (hetero)cumulenes, (hetero)dienes. A few aza and phospha derivatives are exceptions.

6.

Enzymes should be assigned to one of the six main enzyme classes (hydrolases, isomerases, ligases, lyases, oxidoreductases, transferases).

7.

A keyword in the form "N ligand" is only chosen if a considerable portion of the paper deals with the coordination of any ligand that coordinates through the atom concerned (in the example, nitrogen).

This list is a "living" catalogue, flexible enough to absorb new developments in chemistry. We therefore welcome all suggestions from our readers and authors that might improve its user-friendliness.

Experimental Section

Length

Experimental Sections (applicable to Full Papers and Communications only) should be given in sufficient detail to enable others to repeat your work. In papers containing theoretical work, technical details such as computational methods should likewise be confined to an appropriately named section. Experimental Sections have no length restrictions in Full Papers. However, the Editorial Office requests that space be used thoughtfully and economically. Additional experimental details supplementary to those described in the article should be provided as Supporting Information, which will be made accessible on Wiley Online Library. ChemPlusChem will not publish Full Papers that consist mainly of results reported in previous Communications with an added Experimental Section.

If a crystal structure analysis is not an essential part of a manuscript, only a footnote is required indicating where the detailed results can be found. This can be a separate publication or a freely accessible database.

General Comments and Format

The Experimental Section should be written in the past tense. Quantities of reactants, solvents, etc. should be included in parentheses rather than in the running text (e.g., "Triphenylstannyl chloride (0.964 g, 2.5 mmol) in toluene (20 mL)..."). Physical data (in SI units whenever possible) should be quoted with decimal points and negative exponents (e.g., 25.8 JK−1mol−1). Products should be described, and yields should be given as both a quantity (mol or g) and in percent (e.g., "...compound 7 as a white powder (34 mg, 89%)...").

In special cases, for example, when the compound is unstable or not available in sufficient quantities for complete analysis, the exact relative molecular mass obtained from a high-resolution mass spectrum and a clean 13C NMR spectrum (as Supporting Information for inspection by the reviewers) should be supplied.

Data in the Experimental Section should be carefully and consistently formatted according to the journal style. Examples: "...gave compound 7 as a white powder (34 mg, 89%): Rf=0.38 (CHCl3/MeOH 9:1); m.p.: 70–71°C; [α]D20=−13.5 (c=0.2 in acetone); 1H NMR (400 MHz, [D8]THF, 25°C, TMS): δ=0.88 (t, J=7.2 Hz, 3H), 1.21–1.61 (m, 7H), 2.13 (s, 3H), 3.28 (dd, J=9.0, 7.6 Hz, 1H), 6.75 (d, J=7.9 Hz, 2H), 7.45 ppm (t, J=7.3 Hz, 2H); 13C NMR (75 MHz, [D6]DMSO, 25°C, TMS): δ=13.9, 21.2, 124.5 (2C), 125.8 (2C) 147.6, 175.0 ppm; IR (KBr): ν˜==3248, 3056, 1790, 1780, 1506, 1493 cm−1; UV/Vis (CH2Cl2): λmax (ε)=320 (5000), 270 nm (12000 mol−1dm3cm−1); fluorescence (CH2Cl2): λex=435.5 nm; λem=659, 726 nm; MS (EI): m/z (%): 494 [M+H]+, 476, 392, 348, 268, 217, 174, 139, 123, 91 (100), 77, 55, 41; HRMS (ESI): m/z calcd for C32H47NO5+Na+: 548.3352 [M+Na+]; found: 548.3331; elemental analysis calcd (%) for C29H35NO4S (493.7): C 70.56, H 7.15, N 2.84, S 6.50; found: C 70.65, H 7.06, N 2.93, S 6.58. Please give data in this order.

Compound Characterization and Purity

For all new compounds reported in the Experimental Section, sufficient characterization data should be provided to unambiguously identify the structure and to allow identification through comparison by others.

In general, we encourage authors to include as much characterization data as possible for all compounds described, including but not limited to any/all of the following: 1H NMR, 13C NMR, IR, UV/Vis, MS and HRMS data, elemental (combustion) analysis, melting point ranges for solids, Rf values with solvent details. Specific rotation ([α]D20) values should be given for all optically active compounds described.

Those compounds used in biological testing, whether synthesized or obtained from other sources (e.g., commercial), should possess a purity of no less than 95%. Purity may be determined by any established method (e.g., HPLC, elemental analysis with accuracy within ±0.4%). The purity should be stated, along with the method used to determine it, in the Experimental Section and if appropriate, evidence can be provided in the Supporting Information.

Equipment and Software

Equipment (including make, model, and manufacturer if uncommon), and details of any software used (including version, release date if applicable, and developer) and conditions used for the measurement of physical data, as well as any organisms, proteins, or nucleic acids used, should be described at the beginning of the Experimental Section. Sources of less-common starting materials must be given, and solvent details should also be described.

Compound names

In so far as is practical, authors should use a systematic name for each title compound in the Experimental Section (as suggested by IUPAC, IUBMB, or Chemical Abstracts) followed by the compound number. Please do not use computer programs to generate elaborate systematic names or use extremely long compound names.

When describing the protocol for the synthesis of a given title compound, the full name followed by the compound number in parentheses should be given in bold. When referring to the compound in the running text of the protocol, parentheses for the compound number should be used only if the name identifies the compound uniquely and unambiguously (for example: "...2-ethyl-4-cyanobenzoate (7) was added to..." or: "...cyanobenzoate 7 was added to..."). For the sake of clarity general descriptors such as compound 1, dendrimer 2, or alcohol 3 should be used in the running text rather than the full systematic name.

Animal and Human Subjects

Manuscripts containing animal experiments must include a statement that permission was obtained from the relevant national or local authorities. The institutional committees that have approved the experiments must be identified and the accreditation number of the laboratory or of the investigator given where applicable. If no such rules or permissions are in place in the country where the experiments were performed, then this must also be clearly stated.

Manuscripts with experiments with human subjects or tissue samples from human subjects must contain a disclaimer in the Experimental Section to state that informed signed consent was obtained from either the patient or from next of kin.

Structure and Sequence Data

Prior to manuscript submission, the author(s) must deposit the following information in the appropriate databases: the data of X-ray structure analyses of inorganic and organic compounds, proteins, or nucleic acids; structure determination of proteins and nucleic acids by NMR spectroscopy (together with a list of NEOs), and sequence determinations of proteins or nucleic acids. The name of the database and the deposition number(s) assigned by this database must be stated in the part of the manuscript where the respective structure or sequence determination(s) is described so that reviewers can retrieve the information electronically. Detailed instructions for data submission can be found on the WWW homepages of the databases listed below.

If a crystal structure analysis is not an essential part of the paper, only a footnote is required indicating where the detailed results can be found. Otherwise, the following data should be given as a reference in the manuscript: crystal dimensions, crystal system, space group, unit cell dimensions and volume, ρcalcd, 2θmax, radiation, wavelength, scan mode, temperature of measurement, no. of measured and independent reflections, no. of reflections included in refinement, σ limits, whether and how Lorentzian polarization and absorption corrections were performed (μ, min/max transmission), method of structure solution and program, method of refinement and program, no. of parameters, treatment of H atoms. R, wR, whether refined against |F| or |F2|, residual electron density, and the database in which the detailed results are deposited. An ORTEP-type plot will not be reproduced when it merely serves to confirm the structure of a synthetic intermediate.

Structure Data

Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at http://www.ccdc.cam.ac.uk/services/structure_deposit.

Authors must deposit their data before submitting their manuscripts or update data already available, so that reviewers can retrieve the information directly from the database. Please use the free online Checkcif service provided by the International Union of Crystallography and submit the Checkcif report along with your manuscript. Please ensure that the data deposited with the database are identical to those in the manuscript.

The data will be assigned a registry number, which should be included with the following standard text in the manuscript: "CCDC ... contain(s) the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif."

Inorganic compounds, elements, metals, or minerals: Fachinformationszentrum Karlsruhe (FIZ; http://www.fiz-karlsruhe.de).

You will be given a CSD number, which should be included with the following standard text in the manuscript: "Further details of the crystal structure investigation(s) can be obtained from the Fachinformationszentrum Karlsruhe, 76344 Eggenstein-Leopoldshafen, Germany (fax: (+49)7247-808-666; e-mail: crysdata@fiz-karlsruhe.de, http://www.fiz-karlsruhe.de/request_for_deposited_data.html) on quoting the depository number CSD ..."

Proteins and nucleic acids: Protein Data Bank (http://www.rcsb.org/pdb).

NMR spectroscopy data: BioMagResBank (http://www.bmrb.wisc.edu).

Sequence Data

Nucleic acids: GenBank (WWW: http://www.ncbi.nlm.nih.gov/) or EMBL Nucleotide Sequence Database (http://www.ebi.ac.uk/embl/index.html).

Proteins: Protein Information Resource (PIR; http://pir.georgetown.edu/) or SWISS-PROT (http://www.expasy.ch/sprot/sprot-top.html).

Please note that the data in databanks must be released, at the latest, upon publication of your manuscript.

Organization for Full Papers

We can evaluate and process your manuscript more efficiently if it is arranged as described below. Unless stated otherwise, the following instructions apply to all categories of contributions.

Title page: Title; authors′ names with academic titles, an asterisk denotes the correspondence author(s); alphabetical footnotes ([a],[b],...) referring to affiliations of all the authors, including the full postal address and e-mail address of the correspondence author(s); series title, number, and reference to the previous paper in the series, if applicable; dedication, if applicable. Please note: the correspondence author should be the person submitting the manuscript.

Abstract should be brief (maximum 1000 characters excl. spaces, no references) and not too technical.

Introduction should include relevant references.

Results and Discussion may be combined or kept separate and may be further divided by subheadings. This section should not be cluttered with technical details. Abbreviations and acronyms should be used sparingly and consistently. Where they first appear in the text, they should—apart from the most common ones such as NMR, IR, and UV—be defined; you may prefer to explain large numbers of abbreviations and acronyms in a footnote on the first page.

Experimental Section should be in sufficient detail to enable others to repeat your work. In theoretical papers, technical details such as computational methods should likewise be confined to an appropriately named section. Please see the Experimental Section requirements for specific information about formatting and requirements for compound purity and characterization data.

If practical, authors should use a systematic name (IUPAC or Chemical Abstracts) for each title compound in the Experimental Section. Please do not use computer programs to generate elaborate systematic names or use long, multiline compound names; for the sake of clarity general descriptors such as compound 2, dendrimer 3, or alcohol 4 should be used.

Equipment and conditions used for the measurement of physical data should be described at the beginning of the Experimental Section. Quantities of reactants, solvents etc. should be included in parentheses (e.g., triphenylstannyl chloride (0.964 g, 2.5 mmol) in toluene (20 mL)) rather than in the running text. Physical data should be quoted with decimal points and negative exponents (e.g., 25.8 JK−1mol−1). The structure and compositions of all materials central to the manuscript must be disclosed in the main text or in Supporting Information, including commercial and proprietary products, pure materials, and mixtures. Manuscripts reporting results using undisclosed material compositions may not be considered for publication and may be returned without external review. The identity of all new materials and compounds must also be fully characterized by appropriate analytical methods (e.g., electron microscopy, X-ray diffraction, NMR spectroscopy, X-ray crystal structure analysis, elemental analysis). The purity of all new organic compounds should be verified by elemental analysis to an accuracy of within ±0.4%. In special cases, for instance, when the compound is unstable or not available in sufficient quantities for complete analysis, the exact relative molecular mass obtained from a high-resolution mass spectrum and a clean 13C NMR spectrum (as Supporting Information for inspection by the referees) should be supplied.

Computer-aided image enhancement is often unavoidable. However, such manipulation cannot result in data that are less relevant or unrepresentative being shown and/or genuine and significant signals being lost. A clear relationship must remain between the original data and the electronic images that result from those data. If an image has been electronically modified, the form of the modification must be given in the Figure caption. If computer-aided processing or modification of an image is a fundamental part of the experimental work, then the form that this processing takes must be clearly described in the Experimental Section. A common example of this is the presentation of Western blots; authors should state clearly in the figure legend how a gel was modified, and if appropriate, provide the full gels as Supporting Information for consideration by the Editor and Reviewers.

Manuscripts containing animal experiments must include a statement that permission was obtained from the relevant national or local authorities. The institutional committees that have approved the experiments must be identified and the accreditation number of the laboratory or of the investigator given where applicable. If no such rules or permissions are in place in the country where the experiments were performed, then this must also be clearly stated. Manuscripts with experiments with human subjects or tissue samples from human subjects must contain a disclaimer in the Experimental Section to state that informed, signed consent was obtained from either the patient or next of kin.

Acknowledgments should include relevant funding agencies.

References: In the text the numbers should be typed in square brackets as superscripts (e.g., Wittig[3]) and, if applicable, after punctuation. References must be listed in order of their appearance in the text. Please do not format the references section with the Numbering function on your word-processing program. If you use the automatic reference collation system of your word-processing program (Footnotes, EndNote), please convert the references into normal, typed text before submission of the final manuscript, otherwise they may disappear when typeset. Journal titles should be abbreviated according to the Chemical Abstracts Service Source Index (CASSI). Unpublished results and lectures should only be cited for exceptional reasons.

Please follow the examples below. The page range is optional but its presence or absence should be consistent throughout any given manuscript.

Journals: [1] a) B. M. Trost, Chem. Eur. J. 1998, 4, 2405–2412; b) P. Sears, C.-H. Wong, Angew. Chem. Int. Ed. 1999, 38, 2300–2324; Angew. Chem. 1999, 111, 2446–2471. [2] a) W. D. Wagner, Ann. N.Y. Acad. Sci. 1985, 454, 52–68, and references therein; b) Y.-Q. Yang, Y.-K. Wu, Chin. J. Chem. 2005, 23, 1519–1522; c) B. Krebs, H. U. Hürter, Acta Crystallogr. Sect. A 1981, 37, 163.

Books: Without editor: [3] J. Otera, Esterification-Methods, Reactions, and Applications, Wiley-VCH, Weinheim, 2003, p. 55. With editor: [4] M. Kitamura, R. Noyori in Ruthenium in Organic Synthesis (Ed.: S.-I. Murahashi), Wiley-VCH, Weinheim, 2004, pp. 3–52.

Miscellaneous: [5] a) Y. B. Kuang, Q. X. Jia, H. Nishiyama, T. Yamada, A. Kudo, K. Domen, Adv. Energy Mater. 2016, 6, 1501645; b) C. R. A. Botta (Bayer AG), DE-B 2235093, 1973 [Chem. Abstr. 1974, 80, 55356 c]; c) A. Student, PhD thesis, University of Tokyo (Japan), 1991; d) G. Maas, Methoden Org. Chem. (Houben-Weyl) 4th ed. 1952, Vol. E 21/1, pp. 379–397; e) "Synthesis in Biochemistry": R. Robinson, J. Chem. Soc. 1936, 1079; f) S. Novick, "Biography of Rotational Spectra for Weakly Bound Complexes", to be found under http://www.wesleyan.edu/chem/faculty/novick/vdw.html, 2005; g) G. M. Sheldrick, SHELXS-96, Program for the Solution of Crystal Structures, University of Göttingen, Göttingen (Germany), 1996.

Legends: Each Figure and Scheme should have a legend describing the scientific content.

Tables must have a brief title and should only be subdivided by three horizontal lines. Footnotes in tables are denoted [a], [b], [c], etc.

Illustrations (structural formulae, figures, schemes) should, if possible, be designed for reduction to a one-column format (8.5 cm wide). The maximum width is the two-column format (17.5 cm wide). Please note that ChemPlusChem does not use charts; these should be converted into structural formulae or schemes. Further guidelines on the graphical representation standards for chemical structure diagrams have been published by IUPAC. To allow the Editor and Reviewers to easily interpret the graphics, care should be taken to ensure all text is legible and all images are clear and of high quality. We recommend: a sans serif font (e.g., Helvetica) for script; size of lettering, 3–3.5 mm; total maximum width, 14 cm (or 28 cm for two-column width). Please use only one size of writing in any one diagram; if two sizes are absolutely necessary, please keep the font sizes to within 2 pt. Please also use only one style of font; the journal style requires a sans serif font (e.g., Helvetica). Writing above the arrow in a scheme may be a little smaller. Color graphics will be reproduced free of charge.

All graphical material containing structural formulae should be provided as ChemDraw (.cdx) files. Please also refer to the templates under "Author Guidelines" on the ChemPlusChem homepage (www.chempluschem.org).

Figures, Schemes, Tables and other elements: When preparing your manuscript for evaluation by the Editor and Reviewers, graphical elements should appear, with their legend or footnotes if appropriate, within the main text of the article where first mentioned. Each figure and scheme should have a legend. These should be listed immediately below the graphic, within the main body of the manuscript. Tables must have a brief title and should only be subdivided by three horizontal lines (head rule, neck rule, foot rule). Footnotes in tables are denoted [a], [b], [c], etc. and should contain all additional details. For tables reporting biological data, details of the number of independent experiments, the number of replicates, and errors (SD or SEM) should be given either in the table body or as a general statement in the footnote.

Please italicize symbols of physical quantities in both graphics and the text, but not their units (e.g., T for temperature, in contrast to T for the unit Tesla; J, but Hz; a, but nm). Stereochemical information (cis, Z, R, etc.), locants (N-methyl, α-amino), and symmetry designations (C2v) should also be italicized. Chemical formulae should be numbered with boldface Arabic numerals (e.g., 1). Labels of axes should be separated from their units by a slash (e.g., T / K). Abbreviations such as Me, Et, nBu, iPr, sBu, tBu, and Ph (not φ) may be used. General substituents should be indicated by R1, R2 (not R2, which means 2R), or R, R′. The spatial arrangement of the substituents should be indicated by hatched lines or a wedge. A minus sign must be as long as the crossbar of a plus sign. Microscopy images (optical, electron, or scanning probe) should always contain a scale bar.

Mathematical formulae should not be incorporated into the text as graphic files. Please type mathematical formulae as normal text in the body of the text as far as is possible.

Graphical abstract: A short text (approximately 350 characters) with an eye-catching headline for the table of contents should be included as the last page and saved as part of the main text. It should tempt readers to click on the article and need not summarize the entire paper. A graphic should be provided that is kept small with minimum detail. The graphic will be either placed to one side of the text, in which case its size should be 5.5 cm wide × 5.0 cm high (650 pixels x 590 pixels@300 dpi), or above the text across two columns, in which case its size should be 11.0 cm wide × 2.5 cm high (1300 pixels x 245 pixels@300 dpi).

Keywords: A maximum of five keywords should be given in alphabetical order. At least two keywords from the core keyword list (see section on Keywords) should be included to aid online searching.

SEARCH

SEARCH BY CITATION